Autoantibody formation against a 190-kDa antigen of the desmosomal plaque in pemphigus foliaceus

British Journal of Dermatology

Volumn 137, Issue 5, 1997, Pages 774-779

  Ghohestani, R ^a   Joly, P ^a,b   Gilbert, D ^b   Nicolas, J F ^a   Thomine, E ^b   Cozzani, E ^a   Lauret, P H ^b   Claudy, A ^a   Tron, F ^b  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; DESMOGLEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; PEMPHIGUS ANTIBODY; RECOMBINANT PROTEIN;

ADULT; AGED; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CASE REPORT; CATTLE; DESMOSOME; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; NONHUMAN; PARANEOPLASTIC SYNDROME; PEMPHIGUS FOLIACEUS; PRIORITY JOURNAL;

EID: 0030695385     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01117.x     Document Type: Article

References (21)

1. Stanley JR. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid bullous diseases due to defective epidermal cell adhesion. Adv Immunol 1993; 53: 291-325.
2. Stanley JR, Koulu LA, Klaus-Kovtun V, Steinberg MS. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol 1986; 136: 1227-30.
3. Masayuki A, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991; 67: 869-77.
4. Anhalt GJ, Kim SC, Stanley JR et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-35.
5. Joly P, Thomine E, Gilbert D et al. Overlapping distribution of autoantibody specificities in paraneoplastic pemphigus and pemphigus vulgaris. J Invest Dermatol 1994; 103: 65-72.
6. Hashimoto T, Amagai M, Watanabe K et al. Characterization of paraneoplastic pemphigus autoantigens by immunoblot analysis. J Invest Dermatol 1995; 104: 829-34.
7. Dmochowski M, Hashimoto T, Garrod DR et al. Desmocollins I and II are recognized by certain sera from patients with various types of pemphigus, particularly Brazilian pemphigus foliaceus. J Invest Dermatol 1993; 100: 380-4.
8. Joly P, Gilbert D, Thomine E et al. Identification of a new antibody population directed against a desmosomal plaque antigen in pemphigus vulgaris and pemphigus foliaceus. J Invest Dermatol 1997; 108: 469-75.
9. Joly P, Gilbert D, Thomine E et al. Immunofluorescence and immunoelectron microscopy analyses of a human monoclonal anti-epithelial cell surface antibody that recognized a 180-190-kD polypeptide: a component of the paraneoplastic pemphigus antigen complex? J Invest Dermatol 1993; 101: 339-45.
10. Verdier-Sevrain S, Joly P, Thomine E et al. Thiopronine-induced herpetiform pemphigus: report of a case studied by immuno-electron microscopy and immunoblot analysis. Br J Dermatol 1994; 130: 238-40.
11. Peyron E, Nicolas JF, Reano A et al. Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1 (BPAG1). J Immunol 1994; 153: 1333-49.
12. Gammon WR, Briggaman RA, Inman A et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984; 82: 139-44.
13. Ghohestani R, Kanitakis J, Nicolas JF et al. Comparative sensitivity of indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2. Br J Dermatol 1996; 135: 74-9.
14. Gaucherand M, Nicolas JF, Paranhos Baccala G et al. Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C-terminal end of the protein: evidence using a 55 kDa recombinant protein. Br J Dermatol 1995; 132: 190-6.
15. Kawana S, Hashimoto T, Nishikawa T, Nishiyama S et al. Changes in clinical features, histologic findings, and antigen profiles with development of pemphigus foliaceus from pemphigus vulgaris. Arch Dermatol 1994; 130: 1534-8.
16. Chorzelski TP, Hashimoto T, Jablonska S et al. Pemphigus vulgaris transforming into pemphigus foliaceus and their coexistence. Eur J Dermatol 1995; 5: 386-90.
17. Ishiko A, Hashimoto T, Shimizu H et al. Combined features of pemphigus foliaceus and bullous pemphigoid: immunoblot and immunoelectron microscopic studies. Arch Dermatol 1995; 131: 732-4.
18. Ishiko A, Shimizu H, Kikuchi A et al. Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosomes. whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin. J Clin Invest 1993; 91: 1608-15.
19. Joly P, Thomine E, Gilbert D et al. Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in bullous pemphigoid patients. Arch Dermatol 1997; 133: 719-24.
20. Rock B, Anhalt GJ, Labib RS et al. Restricted heterogeneity of IgG subclasses in fogo selvagem (endemic pemphigus foliaceus). N Engl J Med 1989; 320: 1463-9.
21. David M, Katzenelson V, Hazaz B et al. Determination of IgG subclasses in patients with pemphigus with active disease and in remission. Arch Dermatol 1989; 125: 787-90.